The main goal of pre-clinical studies, before administration of a new drug to humans, is to determine its safety profile.
Source BioScience is experienced in supporting regulatory submissions and cross- reactivity studies.
In addition to cross-reactivity testing in tissue using FDA and EMA lists, we offer IHC and FISH analysis together with expert pathology review, providing a comprehensive range of tests to meet our clients' needs.
Cross reactivity testing
Source BioScience offers cross reactivity testing to ascertain adverse reactions in a range of tissues comprising FDA and EMA lists. We have a dedicated project team who can help to develop customised study designs to meet project requirements and deadlines.
For further information and prices please contact us or call +44 (0)115 973 9012